Witteveen A - Search Results

1

Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.

Witteveen A, Kwast AB, Sonke GS, IJzerman MJ, Siesling S. Witteveen A, et al. PLoS One. 2015 Apr 10;10(4):e0120832. doi: 10.1371/journal.pone.0120832. eCollection 2015. PLoS One. 2015. PMID: 25861031 Free PMC article.

2

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.

Witteveen A, Vliegen IM, Sonke GS, Klaase JM, IJzerman MJ, Siesling S. Witteveen A, et al. Breast Cancer Res Treat. 2015 Aug;152(3):627-36. doi: 10.1007/s10549-015-3490-4. Epub 2015 Jul 11. Breast Cancer Res Treat. 2015. PMID: 26162567 Free PMC article.

3

A Validated Prediction Model and Nomogram for Risk of Recurrence in Early Breast Cancer Patients.

Witteveen A, Vliegen IM, Siesling S, IJzerman MJ. Witteveen A, et al. Value Health. 2014 Nov;17(7):A619-20. doi: 10.1016/j.jval.2014.08.2192. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202176 Free article. No abstract available.

4

Survival After Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval.

Witteveen A, Kwast AB, Sonke G, IJzerman MJ, Siesling S. Witteveen A, et al. Value Health. 2014 Nov;17(7):A620. doi: 10.1016/j.jval.2014.08.2193. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202183 Free article. No abstract available.

5

Patterns and predictors of first and subsequent recurrence in women with early breast cancer.

Geurts YM, Witteveen A, Bretveld R, Poortmans PM, Sonke GS, Strobbe LJA, Siesling S. Geurts YM, et al. Among authors: witteveen a. Breast Cancer Res Treat. 2017 Oct;165(3):709-720. doi: 10.1007/s10549-017-4340-3. Epub 2017 Jul 4. Breast Cancer Res Treat. 2017. PMID: 28677011 Free PMC article.

6

Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population.

van Maaren MC, van Steenbeek CD, Pharoah PDP, Witteveen A, Sonke GS, Strobbe LJA, Poortmans PMP, Siesling S. van Maaren MC, et al. Among authors: witteveen a. Eur J Cancer. 2017 Nov;86:364-372. doi: 10.1016/j.ejca.2017.09.031. Epub 2017 Nov 5. Eur J Cancer. 2017. PMID: 29100191 Free article.

7

Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.

de Ligt KM, Witteveen A, Siesling S, Steuten LMG. de Ligt KM, et al. Among authors: witteveen a. BMC Cancer. 2018 Jan 24;18(1):96. doi: 10.1186/s12885-018-3992-7. BMC Cancer. 2018. PMID: 29361911 Free PMC article.

8

Comparison of Logistic Regression and Bayesian Networks for Risk Prediction of Breast Cancer Recurrence.

Witteveen A, Nane GF, Vliegen IMH, Siesling S, IJzerman MJ. Witteveen A, et al. Med Decis Making. 2018 Oct;38(7):822-833. doi: 10.1177/0272989X18790963. Epub 2018 Aug 22. Med Decis Making. 2018. PMID: 30132386

9

Risk-based breast cancer follow-up stratified by age.

Witteveen A, Otten JWM, Vliegen IMH, Siesling S, Timmer JB, IJzerman MJ. Witteveen A, et al. Cancer Med. 2018 Oct;7(10):5291-5298. doi: 10.1002/cam4.1760. Epub 2018 Sep 11. Cancer Med. 2018. PMID: 30207076 Free PMC article.

10

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.

van Steenbeek CD, van Maaren MC, Siesling S, Witteveen A, Verbeek XAAM, Koffijberg H. van Steenbeek CD, et al. Among authors: witteveen a. BMC Med Res Methodol. 2019 Jun 8;19(1):117. doi: 10.1186/s12874-019-0761-5. BMC Med Res Methodol. 2019. PMID: 31176362 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters